secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001213900-23-085220
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q3 revenues down 57% YoY to $3.9M; net loss of $1.5M
----------------------------------------------------------------------

- Revenues $3.9M vs $9.0M Q3 2022; net loss $1.5M ($0.09/sh) vs net income $1.8M ($0.11) prior year.
- Adjusted EBITDA negative $1.7M vs positive $2.3M a year ago.
- Shipped 11 SRT units (3 outside US, 5 to one large customer); cash $20.5M, no debt.
- Board approved $3.0M stock repurchase program.
- Submitted 510(k) for aesthetic drug delivery system; expects completion by end of 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390023085220/0001213900-23-085220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390023085220/ea187860-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-085220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer